Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Vanaerschot

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
FEMS Microbiology Reviews|July 3, 2013
Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms raceManu Vanaerschot, Silvie Huijben, Frederik Van den Broeck, et al.
Critical Reviews in Microbiology|September 7, 2012
Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?Manu Vanaerschot, Saskia Decuypere, Maya Berg, et al.
Parasitology|March 14, 2013
(Post-) Genomic approaches to tackle drug resistance in LeishmaniaMaya Berg, An Mannaert, Manu Vanaerschot, et al.
Computational and Structural Biotechnology Journal|April 2, 2014
LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test caseMaya Berg, Manu Vanaerschot, Andris Jankevics, et al.
Plos One|August 11, 2011
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burdenManu Vanaerschot, Simonne De Doncker, Suman Rijal, et al.
Plos Neglected Tropical Diseases|January 4, 2013
Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, IndiaAnette Stauch, Hans-Peter Duerr, Jean-Claude Dujardin, et al.
FEMS Microbiology Reviews|July 13, 2016
Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hostsGuy Caljon, Géraldine De Muylder, Lies Durnez, et al.
Expert Review of Anti-Infective Therapy|May 8, 2014
Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?Manu Vanaerschot, Franck Dumetz, Syamal Roy, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 17, 2010
Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from IndiaPankaj Srivastava, Vijay Kumar Prajapati, Manu Vanaerschot, et al.
The American Journal of Tropical Medicine and Hygiene|August 28, 2013
In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasisVijay Kumar Prajapati, Smriti Sharma, Madhukar Rai, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
FEMS Microbiology Reviews|July 3, 2013
Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms raceManu Vanaerschot, Silvie Huijben, Frederik Van den Broeck, et al.
Critical Reviews in Microbiology|September 7, 2012
Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?Manu Vanaerschot, Saskia Decuypere, Maya Berg, et al.
Parasitology|March 14, 2013
(Post-) Genomic approaches to tackle drug resistance in LeishmaniaMaya Berg, An Mannaert, Manu Vanaerschot, et al.
Computational and Structural Biotechnology Journal|April 2, 2014
LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test caseMaya Berg, Manu Vanaerschot, Andris Jankevics, et al.
Plos One|August 11, 2011
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burdenManu Vanaerschot, Simonne De Doncker, Suman Rijal, et al.
Plos Neglected Tropical Diseases|January 4, 2013
Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, IndiaAnette Stauch, Hans-Peter Duerr, Jean-Claude Dujardin, et al.
FEMS Microbiology Reviews|July 13, 2016
Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hostsGuy Caljon, Géraldine De Muylder, Lies Durnez, et al.
Expert Review of Anti-Infective Therapy|May 8, 2014
Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?Manu Vanaerschot, Franck Dumetz, Syamal Roy, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 17, 2010
Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from IndiaPankaj Srivastava, Vijay Kumar Prajapati, Manu Vanaerschot, et al.
The American Journal of Tropical Medicine and Hygiene|August 28, 2013
In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasisVijay Kumar Prajapati, Smriti Sharma, Madhukar Rai, et al.
Pageof 6